TBF1.F - Canntab Therapeutics Limited

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-05-31
2018-05-31
2017-12-31
2017-05-31
2016-12-31
Total Revenue
318.333
239.999
26.667
0
0
942.355
Operating Expenses
Research Development
130.861
128.144
140.732
-
40.685
-
Selling General and Administrative
2,262
2,437
2,258
188.001
1,074
311.524
Total Operating Expenses
2,613
2,742
2,450
188.001
1,117
311.524
Operating Income or Loss
-2,295
-2,502
-2,423
-188.001
-1,117
630.831
Total Other Income/Expenses Net
-
-
-
5.554
-
-111.054
Income Before Tax
-2,282
-2,459
-2,408
-182.447
-1,116
519.777
Income from Continuing Operations
-2,282
-2,459
-2,408
-182.447
-1,116
519.777
Net Income
-2,282
-2,459
-2,408
-182.447
-1,116
519.777
Net Income available to common shareholders
-2,282
-2,459
-2,408
-182.447
-1,116
519.777
Basic EPS
-
-0.10
-0.11
-0.40
-0.07
1.20
Diluted EPS
-
-0.10
-0.11
-0.40
-0.07
1.00
Basic Average Shares
-
25,299
21,129
556.339
15,000
451.61
Diluted Average Shares
-
25,299
21,129
556.339
15,000
519.777
EBITDA
-
-2,421
-2,372
-188.001
-1,115
630.831